Search research articles
Contact Us
Filters
Showing results (441-450 of 494) with videos related to
Page
of 50
Sort By:
Prevention Science : the Official Journal of the Society for Prevention Research
|
February 4, 2025
Indigenous Community-Level Protective Factors in the Prevention of Suicide: Enlarging a Definition of Cultural Continuity in Rural Alaska Native Communities
James Allen, Lisa Wexler, Charlene Aqpik Apok, et al.
Journal of Medicinal Chemistry
|
November 7, 2024
Discovery of SD-436: A Potent, Highly Selective and Efficacious STAT3 PROTAC Degrader Capable of Achieving Complete and Long-Lasting Tumor Regression
Renqi Xu, Haibin Zhou, Longchuan Bai, et al.
Pilot and Feasibility Studies
|
February 7, 2026
SmartAPPetite For Youth: pilot and feasibility study of an adolescent smartphone nutrition intervention
J Gilliland, D Bowman, S Cappuccitti, et al.
Cancer Cell
|
November 13, 2019
A Potent and Selective Small-Molecule Degrader of STAT3 Achieves Complete Tumor Regression In Vivo
Longchuan Bai, Haibin Zhou, Renqi Xu, et al.
Journal of Medicinal Chemistry
|
November 13, 2020
Discovery of CJ-2360 as a Potent and Orally Active Inhibitor of Anaplastic Lymphoma Kinase Capable of Achieving Complete Tumor Regression
Jianyong Chen, Yunlong Zhou, Xuyuan Dong, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 27, 2010
Synthesis and SAR of novel CXCR4 antagonists that are potent inhibitors of T tropic (X4) HIV-1 replication
Renato Skerlj, Gary Bridger, Ernie McEachern, et al.
Plos One
|
December 17, 2009
Establishment, immortalisation and characterisation of pteropid bat cell lines
Gary Crameri, Shawn Todd, Samantha Grimley, et al.
Journal of Medicinal Chemistry
|
October 6, 2021
Discovery of EEDi-5273 as an Exceptionally Potent and Orally Efficacious EED Inhibitor Capable of Achieving Complete and Persistent Tumor Regression
Rohan Kalyan Rej, Changwei Wang, Jianfeng Lu, et al.
Journal of Medicinal Chemistry
|
November 21, 2019
Structure-Based Discovery of SD-36 as a Potent, Selective, and Efficacious PROTAC Degrader of STAT3 Protein
Haibin Zhou, Longchuan Bai, Renqi Xu, et al.
Journal of Medicinal Chemistry
|
July 1, 2021
Discovery of M-1121 as an Orally Active Covalent Inhibitor of Menin-MLL Interaction Capable of Achieving Complete and Long-Lasting Tumor Regression
Meng Zhang, Angelo Aguilar, Shilin Xu, et al.
Page
of 50
Search research articles
Search
Showing results (441-450 of 494) with videos related to
Sort By:
Page
of 50
Prevention Science : the Official Journal of the Society for Prevention Research
|
February 4, 2025
Indigenous Community-Level Protective Factors in the Prevention of Suicide: Enlarging a Definition of Cultural Continuity in Rural Alaska Native Communities
James Allen, Lisa Wexler, Charlene Aqpik Apok, et al.
Journal of Medicinal Chemistry
|
November 7, 2024
Discovery of SD-436: A Potent, Highly Selective and Efficacious STAT3 PROTAC Degrader Capable of Achieving Complete and Long-Lasting Tumor Regression
Renqi Xu, Haibin Zhou, Longchuan Bai, et al.
Pilot and Feasibility Studies
|
February 7, 2026
SmartAPPetite For Youth: pilot and feasibility study of an adolescent smartphone nutrition intervention
J Gilliland, D Bowman, S Cappuccitti, et al.
Cancer Cell
|
November 13, 2019
A Potent and Selective Small-Molecule Degrader of STAT3 Achieves Complete Tumor Regression In Vivo
Longchuan Bai, Haibin Zhou, Renqi Xu, et al.
Journal of Medicinal Chemistry
|
November 13, 2020
Discovery of CJ-2360 as a Potent and Orally Active Inhibitor of Anaplastic Lymphoma Kinase Capable of Achieving Complete Tumor Regression
Jianyong Chen, Yunlong Zhou, Xuyuan Dong, et al.
Bioorganic & Medicinal Chemistry Letters
|
November 27, 2010
Synthesis and SAR of novel CXCR4 antagonists that are potent inhibitors of T tropic (X4) HIV-1 replication
Renato Skerlj, Gary Bridger, Ernie McEachern, et al.
Plos One
|
December 17, 2009
Establishment, immortalisation and characterisation of pteropid bat cell lines
Gary Crameri, Shawn Todd, Samantha Grimley, et al.
Journal of Medicinal Chemistry
|
October 6, 2021
Discovery of EEDi-5273 as an Exceptionally Potent and Orally Efficacious EED Inhibitor Capable of Achieving Complete and Persistent Tumor Regression
Rohan Kalyan Rej, Changwei Wang, Jianfeng Lu, et al.
Journal of Medicinal Chemistry
|
November 21, 2019
Structure-Based Discovery of SD-36 as a Potent, Selective, and Efficacious PROTAC Degrader of STAT3 Protein
Haibin Zhou, Longchuan Bai, Renqi Xu, et al.
Journal of Medicinal Chemistry
|
July 1, 2021
Discovery of M-1121 as an Orally Active Covalent Inhibitor of Menin-MLL Interaction Capable of Achieving Complete and Long-Lasting Tumor Regression
Meng Zhang, Angelo Aguilar, Shilin Xu, et al.
Page
of 50